Simultaneous measurement of drug metabolic stability and identification of metabolites using ion-trap mass spectrometry

Rapid Communications in Mass Spectrometry

Volumn 17, Issue 23, 2003, Pages 2661-2668

  Kantharaj, E ^a   Tuytelaars, An ^a   Proost, Pascale E A ^a   Ongel, Zuleyha ^a   Van Assouw, Harrie P ^a   Gilissen, Ron A H J ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMOLECULES; CHROMATOGRAPHIC ANALYSIS; DRUG PRODUCTS; IONS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; STABILITY;

CISAPRIDE; DRUG METABOLISMS; IN-VITRO; IN-VIVO; ION-TRAP MASS SPECTROMETRY; MEASUREMENTS OF; METABOLIC STABILITY; SIMULTANEOUS MEASUREMENT; VERAPAMIL; VIVO PHARMACOKINETICS;

METABOLITES;

CISAPRIDE; DRUG METABOLITE; FLUNARIZINE; PROPRANOLOL; VERAPAMIL;

CONFERENCE PAPER; DRUG INDUSTRY; DRUG METABOLISM; DRUG SAFETY; DRUG STABILITY; DRUG TOXICITY; HUMAN TISSUE; IN VITRO STUDY; ION TRAP MASS SPECTROMETRY; LIVER; MASS SPECTROMETRY; MEASUREMENT; PHARMACOKINETICS;

EID: 0344233243     PISSN: 09514198     EISSN: None     Source Type: Journal    
DOI: 10.1002/rcm.1228     Document Type: Conference Paper

References (28)

1. Houng-Yau M, Czarnik AW. In Integrated Drug Discovery Technologies, Marcel Dekker, Inc.: New York, 2002.
2. Parkinson P. Trends Microbiol. 2002; 10: s22.
3. Murphy SA, Massi JM, Richardson PM. J. Proteome Res. 2002; 1: 531.
4. Jain HK. Drug Discovery Today 2001; 6: 772.
5. Watt A, Morrison D. Drug Discovery Today 2001; 6: 290.
6. Warmus JS. Drug Discovery Today 1999; 4: 7.
7. Beavers MP, Chen X. J. Mol. Graphics Modelling 2002; 20:463.
8. Lee MS, Kerns EH. Mass Spectrom. Rev. 1999; 18: 187.
9. Peng SX. Biomed. Chromatogr. 2000; 14: 430.
10. Thompson TN. Med. Res. Rev. 2001; 21: 412.
11. Frenette R, Blouin M, Brideau C, Chauret N, Ducharme Y, Friesen RW, Hamel P, Jones TR, Laliberte' Chun Li F, Masson P, McAulie M, Girard Y. Bioorg. Med. Chem. Lett. 2002; 12: 3009.
12. Wyatt PG, Allen MJ, Chilcott J, Hickin G, Miller ND, Woollard PM. Bioorg. Med. Chem. Lett. 2001; 11: 1301.
13. Cai Z, Sinhababu AK, Harrelson S. Rapid Commun. Mass Spectrom. 2000; 14: 1637.
14. Dear GJ, Ayrton J, Plumb R, Fraser IJ. Rapid Commun. Mass Spectrom. 1999; 13: 456.
15. Gangl E, Utkin I, Gerber N, Vouros P. J. Chromatogr. A 2002; 974: 91.
16. Mass Spectrometry in Drug Discovery, Rossi DT, Sinz MIW (eds). Marcel Dekker, Inc.: New York, 2002.
17. Bertrand M, Jackson P, Walther B. Eur. J. Pharm. Sci. 2000; 11: S61.
18. Tiller PR, Romanyshyn LA. Rapid Commun. Mass Spectrom. 2002; 16: 1225.
19. Nassar AEF, Bjorge SM, Lee DY. Anal. Chem. 2003; 75: 785.
20. Zhang N, Fountain ST, Bi H, Rossi DT. Anal. Chem. 2000; 72: 800.
21. Gu M, Lim HK. J. Mass Spectrom. 2001; 36:1053.
22. Korfmacher WA, Palmer CA, Nardo C, Dunn-Meynell K, Grotz D, Cox K, Lin CC, Elicone C, Liu C, Duchoslav E. Rapid Commun. Mass Spectrom. 1999; 13: 901.
23. Choi SJ, Ji HY, Baek SK, Lee HY, Choi JK, Cheon HG, Lee DH, Lim H, Lee HS. J. Pharm. Biomed. Anal. 2002; 28: 897.
24. Iatsimirskaia E, Tulebaev, Storozhuk E, Utkin I, Smith D, Gerber N, Koudriakova T. Clin. Phormacol. Ther. 1997; 61: 554.
25. Walles M, Mullett WM, Levsen K, Borlak J, Wunsch G, Pawliszyn J. J. Pharm. Biomed. Anal. 2002; 30: 307.
26. Wu X, Noda A, Noda H, Eto S, Muro H, Ono Y, Inokuchi K. UOEH 2001; 23: 23.
27. Pearce RE, Gotschall RR, Kearns GL, Leeder JS. Drug Metab. Dispos. 2001; 29: 1548.
28. Garnett WR, Venitz J, Kroner B, Schlroot JT, Pledger GW, Sackellares JC, Treiman DM, Pellock JM, Wright FJ, Makati MS. Epilepsia 1994; 35: 94.